drugset / Trial / NCT00769899
AZD7325 Single Ascending Dose Study in Healthy Male Japanese Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase I randomized double-blind, placebo-controlled, single centre study to assess the safety, tolerability and pharmacokinetics of AZD7325 following single ascending dose administration to healthy male Japanese volunteers.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD7325 | Small molecule | — | Oral |
Indications
No indication recorded.